Zinzino AB: Q2 2026 Sales Increased 17 Percent

Zinzino AB has released a preliminary sales report for the second quarter of 2026, indicating significant growth. The group's total revenue increased by 17 percent year-on-year, reaching SEK 302.8 million. In comparison, the revenue for the same period last year stood at SEK 264.2 million.

Revenue from Zinzino's sales markets saw a 17 percent rise in the second quarter, amounting to SEK 914.9 million compared to SEK 779.5 million in the prior year. This growth highlights the company's solid performance in its core markets.

Additionally, subsidiary Faun Pharma's external sales contributed SEK 6.0 million (up from SEK 4.9 million). Although smaller in proportion to the group's total revenue, Faun Pharma's growth supports the overall positive trend.

For the month of June specifically, Zinzino's sales markets reported a 14 percent increase in revenue, totaling SEK 296.8 million. This momentum at the end of the quarter suggests continued strength heading into future reporting periods.